Bei F. Wang
Tianjin Key Laboratory Of Technologies Enabling Development Of Clinical Therapeutics And Diagnostics, Key Laboratory Of Immune Microenvironment And Disease
Tianjin, China
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
BRD4770 protects against DOX-induced cardiotoxicity by inhibiting apoptosis and ferroptosis.
Journal: Science advances
Published: July 11, 2025
Dot1L Promotes Stress-Induced Cardiac Hypertrophy in Mice via Tbx6.
Journal: Circulation research
Published: June 30, 2025
CRTH2 is critical for IL-1β-producing B cells during experimental autoimmune encephalomyelitis in mice via p38 signaling.
Journal: Journal of neuroinflammation
Published: May 21, 2025
Notch2 Signaling Drives Cardiac Hypertrophy by Suppressing Purine Nucleotide Metabolism.
Journal: Research (Washington, D.C.)
Published: November 20, 2024
Network Pharmacology Analysis and Retrospective Cohort Study Revealing the Effect of Qingyi Decoction on Intestinal Paralysis in Patients with Severe Acute Pancreatitis.
Journal: Current pharmaceutical design
Published: May 06, 2024
Thromboxane A2 Modulates de novo Synthesis of Adrenal Corticosterone in Mice via p38/14-3-3γ/StAR Signaling.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 20, 2023
EP1 activation inhibits doxorubicin-cardiomyocyte ferroptosis via Nrf2.
Journal: Redox biology
Published: June 02, 2023
Clinical observation of electroacupuncture combined with Qingyi Xianxiong Decoction in the treatment of acute respiratory distress syndrome due to severe acute pancreatitis
Journal: Zhonghua wei zhong bing ji jiu yi xue
Published: December 26, 2022
Protective effects of CRTH2 suppression in dry age-related macular degeneration.
Journal: Biochemical and biophysical research communications
Published: June 13, 2022
Identification of mouse lines with HA-tagged prostaglandin receptors
Journal: Sheng li xue bao : [Acta physiologica Sinica]
Published: August 18, 2021
Dopamine D1 receptor alleviates doxorubicin-induced cardiac injury by inhibiting NLRP3 inflammasome.
Dopamine D1 receptor alleviates doxorubicin-induced cardiac injury by inhibiting NLRP3 inflammasome.
Journal: Biochemical and biophysical research communications
Published: April 18, 2021
Last Updated: 09/26/2026